PUBLISHER: Lucintel | PRODUCT CODE: 1263900
PUBLISHER: Lucintel | PRODUCT CODE: 1263900
3D Bioprinting Market Trends and Forecast
The future of the 3D bioprinting market looks promising with opportunities in the pharmaceutical & biotechnology and research organizations & academic institutes. The global 3D bioprinting market is expected to reach an estimated $5.0 billion by 2028 with a CAGR of 18.4% from 2023 to 2028. The major drivers for this market are growing demand for organ transplantation, rise in public and private funding to support research activities, and increasing usage of 3D bioprinting in cosmetic surgeries and drug discovery process.
3D Bioprinting Market by Technology, Product, Material, Application, End Use Industry, and Region
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
3D Bioprinting Market by Segments
3D Bioprinting Market by Segment
3D Bioprinting Market by Technology [Value ($B) Shipment Analysis from 2017 to 2028]:
Magnetic 3D Bioprinting
Laser-assisted Bioprinting
Inkjet 3D Bioprinting
Microextrusion 3D Bioprinting
Methyl Mercaptan Sensors
Others
3D Bioprinting Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:
3D Bioprinters
Biomaterials
Scaffolds
3D Bioprinting Market by Material [Value ($B) Shipment Analysis from 2017 to 2028]:
Living Cells
Extracellular Matrices
Hydrogels
Others
3D Bioprinting Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:
Clinical Applications
Skin
Bones
Blood Vessels
Research Applications
Drug and Medical Research
Regenerative Medicine
3D Cell Culture
3D Bioprinting Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:
Pharmaceutical & Biotechnology Companies
Research Organizations & Academic Institutes
Others
3D Bioprinting Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
North America
Europe
Asia Pacific
The Rest of the World
List of 3D Bioprinting Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, 3D bioprinting companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the 3D bioprinting companies profiled in this report include-
Organovo Holdings
Envisiontec
Nano 3D Biosciences
Cyfuse Biomedical
Regenhu
3D Bioprinting Market Insights
Lucintel forecasts that 3D bioprinters will remain the largest product segment over the forecast period due to the increasing number of clinical trials and drug testing process, which will help in significantly reducing animal testing.
Research organizations & academic institutes are expected to remain the largest end use industry segment due to the expanding research into portable 3D bioprinting technology that can be used to conveniently generate skin tissues and reduce scars in trauma care.
North America will remain the largest region due to growing prevalence of chronic diseases, sophisticated healthcare infrastructure along with high disposable income levels in the region, and extensive research activities.
Features of the 3D Bioprinting Market
Market Size Estimates: 3D bioprinting market size estimation in terms of value ($B)
Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
Segmentation Analysis: 3D bioprinting market size by various segments, such as technology, product, material, application, end use industry, and region
Regional Analysis: 3D bioprinting market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
Growth Opportunities: Analysis on growth opportunities in different technology, products, materials, applications, end use industries, and regions for the 3D bioprinting market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape for the 3D bioprinting market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the 3D bioprinting market size?
Answer: The global 3D bioprinting market is expected to reach an estimated $5.0 billion by 2028.
Q2. What is the growth forecast for 3D bioprinting market?
Answer: The global 3D bioprinting market is expected to grow with a CAGR of 18.4% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the 3D bioprinting market?
Answer: The major drivers for this market are growing demand for organ transplantation, rise in public and private funding to support research activities, and increasing usage of 3D bioprinting in cosmetic surgeries and drug discovery process.
Q4. What are the major segments for 3D bioprinting market?
Answer: The future of the 3D bioprinting market looks promising with opportunities in pharmaceutical & biotechnology and research organizations & academic institutes.
Q5. Who are the key 3D bioprinting companies?
Answer: Some of the key 3D bioprinting companies are as follows:
Organovo Holdings
Envisiontec
Nano 3D Biosciences
Cyfuse Biomedical
Regenhu
Q6. Which 3D bioprinting segment will be the largest in the future?
Answer: Lucintel forecasts that 3D bioprinters will remain the largest product segment over the forecast period due to the increasing number of clinical trials and drug testing process, which will help in significantly reducing animal testing.
Q7. In 3D bioprinting market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to growing prevalence of chronic diseases, sophisticated healthcare infrastructure along with high disposable income levels in the region, and extensive research activities.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.